8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
LABCORP HOLDINGS INC. (LH)

Labcorp executives to speak at Morgan Stanley healthcare conference

Filed with the SEC on · Summarized by InvestorsBot

Labcorp said members of its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, at 11:30 a.m. ET. The event will be webcast on Labcorp’s investor relations website and available for replay for 180 days; the filing provided no new financial results, guidance or transaction details.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from LABCORP HOLDINGS INC.

Labcorp to outline strategy and financial outlook at September 10 Investor Day

8-K · August 17, 2026

Labcorp’s Megan Bailey to Resign; Brian Caveney to Lead Biopharma Laboratory Services

8-K · August 14, 2026

Labcorp CEO Adam Schechter sells $1.5M in stock

Form 4 · Insider Trade · August 12, 2026

Labcorp Raises 2026 Guidance After Strong Second-Quarter Results

8-K · July 30, 2026

Labcorp ($LH) 8‑K: Term Loan Credit Agreement dated Mar 20, 2026 among Labcorp Holdings and lenders;…

8-K · March 20, 2026

LABCORP ($LH) 8-K filed 2026-03-20 — Item 2.03 states it incorporates Item 1.01 by reference re: creation…

8-K · March 20, 2026